FDA’s Independent Advisory Panel Votes in Favor of Two RSV Vaccines March 2, 2023 The FDA’s independent advisory panel voted in favor of two vaccines for respiratory syncytial virus (RSV). The vaccines, developed by GSK and Pfizer for people Read More »